Drugs that contain Avatrombopag Maleate
1. Drug name - DOPTELET
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7638536 | AKARX INC | 2-Acylaminothiazole derivative or salt thereof |
May, 2025
(2 years from now) | |
| CN1639157A | AKARX INC | 2-Acylamino-Thiazole Derivative Or Salt Thereof |
Jan, 2023
(3 months from now) | |
| CN1319967C | AKARX INC | 2-Acylamino-Thiazole Derivative Or Salt Thereof |
Jan, 2023
(3 months from now) | |
| IN218532B | AKARX INC | A Pharmaceutical Composition For Increasing The Number Of Platelets |
Jan, 2023
(3 months from now) | |
| IN200400942P2 | AKARX INC | 2-Acylamino Thiazole Derivative Or Its Salt |
Jan, 2023
(3 months from now) | |
| EP2314586A1 | AKARX INC | 2-Acylaminothiazole Derivative Or Salt Thereof |
Jan, 2023
(3 months from now) | |
| EP2314586B1 | AKARX INC | 2-Acylaminothiazole Derivative Or Salt Thereof |
Jan, 2023
(3 months from now) | |
| EP1466912A1 | AKARX INC | 2-Acylaminothiazole Derivative Or Salt Thereof |
Jan, 2023
(3 months from now) | |
| EP1466912B1 | AKARX INC | 2-Acylaminothiazole Derivative Or Salt Thereof |
Jan, 2023
(3 months from now) | |
| EP1466912A4 | AKARX INC | 2-Acylaminothiazole Derivative Or Salt Thereof |
Jan, 2023
(3 months from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8765764 | AKARX INC | 2-acylaminothiazole derivative or salt thereof |
Jan, 2023
(3 months from now) | |
| US8338429 | AKARX INC | 2-acylaminothiazole derivative or salt thereof |
Jun, 2023
(8 months from now) | |
Treatment: Treatment of thrombocytopenia in an adult patient with chronic liver disease who is scheduled to undergo a procedure using doptelet; treatment of thrombocytopenia in an adult patient with chronic liver disease who is scheduled to undergo a procedure; Treatment of thrombocytopenia in an adult patient with chronic immune thrombocytopenia who has had an insufficient response to a previous treatment
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 20MG BASE | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.